ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04360	Axon guidance	8/43	233/7206	5.76983030833e-05
ko05224	Breast cancer	7/43	174/7206	6.56134594844e-05
ko05218	Melanoma	5/43	85/7206	0.00013727732925
ko05213	Endometrial cancer	4/43	62/7206	0.000477002162273
ko05215	Prostate cancer	4/43	111/7206	0.00414526465726
ko04810	Regulation of actin cytoskeleton	6/43	264/7206	0.0044537699351
ko04015	Rap1 signaling pathway	6/43	278/7206	0.0057239797412
ko05221	Acute myeloid leukemia	3/43	63/7206	0.00612801229061
ko05200	Pathways in cancer	8/43	492/7206	0.00773206350688
ko05210	Colorectal cancer	3/43	86/7206	0.0143649525646
ko01521	EGFR tyrosine kinase inhibitor resistance	3/43	106/7206	0.024946514198
ko04151	PI3K-Akt signaling pathway	6/43	390/7206	0.0269964522078
ko04070	Phosphatidylinositol signaling system	3/43	112/7206	0.0287578583
ko04010	MAPK signaling pathway	5/43	321/7206	0.0409429642679
ko05033	Nicotine addiction	2/43	56/7206	0.0437184179792
ko04931	Insulin resistance	3/43	137/7206	0.0477701231165